Literature DB >> 21912417

Chemotherapy: Electromotive mitomycin in superficial bladder cancer.

Willem Oosterlinck.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21912417     DOI: 10.1038/nrclinonc.2011.140

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  9 in total

1.  Electromotive instillation of mitomycin immediately before transurethral resection for patients with primary urothelial non-muscle invasive bladder cancer: a randomised controlled trial.

Authors:  Savino M Di Stasi; Marco Valenti; Cristian Verri; Emanuele Liberati; Arcangelo Giurioli; Gioia Leprini; Francesco Masedu; Antonio R Ricci; Francesco Micali; Giuseppe Vespasiani
Journal:  Lancet Oncol       Date:  2011-08-08       Impact factor: 41.316

2.  Intravesical electromotive drug administration technique: preliminary results and side effects.

Authors:  C R Riedl; M Knoll; E Plas; H Pflüger
Journal:  J Urol       Date:  1998-06       Impact factor: 7.450

Review 3.  EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update.

Authors:  Marko Babjuk; Willem Oosterlinck; Richard Sylvester; Eero Kaasinen; Andreas Böhle; Juan Palou-Redorta; Morgan Rouprêt
Journal:  Eur Urol       Date:  2011-03-22       Impact factor: 20.096

Review 4.  The role of a combined regimen with intravesical chemotherapy and hyperthermia in the management of non-muscle-invasive bladder cancer: a systematic review.

Authors:  Rianne J M Lammers; J Alfred Witjes; Brant A Inman; Ilan Leibovitch; Menachem Laufer; Ofer Nativ; Renzo Colombo
Journal:  Eur Urol       Date:  2011-04-20       Impact factor: 20.096

5.  Intravesical electromotive administration of drugs for treatment of superficial bladder cancer: a comparative Phase II study.

Authors:  M Brausi; B Campo; G Pizzocaro; P Rigatti; A Parma; G Mazza; A Vicini; R L Stephen
Journal:  Urology       Date:  1998-03       Impact factor: 2.649

6.  Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial.

Authors:  Savino M Di Stasi; Antonella Giannantoni; Arcangelo Giurioli; Marco Valenti; Germano Zampa; Luigi Storti; Francesco Attisani; Andrea De Carolis; Giovanni Capelli; Giuseppe Vespasiani; Robert L Stephen
Journal:  Lancet Oncol       Date:  2006-01       Impact factor: 41.316

7.  Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study.

Authors:  Savino M Di Stasi; Antonella Giannantoni; Robert L Stephen; Giovanni Capelli; Pierluigi Navarra; Renato Massoud; Giuseppe Vespasiani
Journal:  J Urol       Date:  2003-09       Impact factor: 7.450

Review 8.  Electromotive drug administration with mitomycin C for intravesical treatment of non-muscle invasive transitional cell carcinoma.

Authors:  Jas Kalsi; Stephen J Harland; Mark R Feneley
Journal:  Expert Opin Drug Deliv       Date:  2008-01       Impact factor: 6.648

9.  A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials.

Authors:  Richard J Sylvester; Willem Oosterlinck; Adrian P M van der Meijden
Journal:  J Urol       Date:  2004-06       Impact factor: 7.450

  9 in total
  3 in total

1.  Association between NAD(P)H:quinone oxidoreductase 1 rs1800566 polymorphism and risk of bladder cancer.

Authors:  Hui Zhang; Xiuhua Wen; Xueren Lu; Hui Zhang
Journal:  Tumour Biol       Date:  2013-07-20

2.  The MMP-1, MMP-2, and MMP-9 gene polymorphisms and susceptibility to bladder cancer: a meta-analysis.

Authors:  Yulan Yan; Hongjie Liang; Taijie Li; Meng Li; Ruolin Li; Xue Qin; Shan Li
Journal:  Tumour Biol       Date:  2014-01-05

3.  Efficient intravesical therapy of bladder cancer with cationic doxorubicin nanoassemblies.

Authors:  Xun Jin; Peilan Zhang; Li Luo; Hao Cheng; Yunzu Li; Ting Du; Bingwen Zou; Maling Gou
Journal:  Int J Nanomedicine       Date:  2016-09-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.